Vero, Vittoria
 Distribuzione geografica
Continente #
EU - Europa 914
NA - Nord America 766
AS - Asia 188
AF - Africa 3
Continente sconosciuto - Info sul continente non disponibili 2
OC - Oceania 2
Totale 1.875
Nazione #
US - Stati Uniti d'America 763
DE - Germania 473
SE - Svezia 155
CN - Cina 114
UA - Ucraina 92
IE - Irlanda 43
IT - Italia 38
FI - Finlandia 31
SG - Singapore 31
FR - Francia 28
GB - Regno Unito 21
RU - Federazione Russa 20
TR - Turchia 19
IN - India 11
IR - Iran 8
JP - Giappone 5
CH - Svizzera 4
RO - Romania 4
BE - Belgio 3
AU - Australia 2
RE - Reunion 2
A2 - ???statistics.table.value.countryCode.A2??? 1
BZ - Belize 1
CA - Canada 1
CI - Costa d'Avorio 1
CZ - Repubblica Ceca 1
EU - Europa 1
HR - Croazia 1
MX - Messico 1
Totale 1.875
Città #
Chandler 153
Ashburn 85
Jacksonville 57
Dublin 42
San Mateo 39
Nanjing 37
Chicago 36
Nürnberg 27
Dearborn 24
Wilmington 23
Boston 20
Munich 20
Izmir 19
Marseille 19
Singapore 18
New York 17
Milan 15
Ann Arbor 14
Helsinki 14
Houston 13
Princeton 13
Nanchang 12
Moscow 11
Woodbridge 9
Redwood City 8
Washington 7
Beijing 6
Detroit 6
Mountain View 6
Norwalk 6
San Diego 6
University Park 6
Bremen 5
Hebei 5
Kunming 5
Lawrence 5
Los Angeles 5
San Jose 5
Seattle 5
Shenyang 5
Tabriz 5
Changsha 4
Fairfield 4
Fremont 4
Guangzhou 4
Hefei 4
Portland 4
Tianjin 4
Boardman 3
Brussels 3
Jiaxing 3
Jinan 3
Nuremberg 3
Phoenix 3
Zurich 3
Andover 2
Cattolica 2
Clayton 2
Como 2
Hangzhou 2
Kish 2
Leawood 2
Ningbo 2
Orangeburg 2
Saint-Pierre 2
Shanghai 2
Simi Valley 2
Verona 2
Abidjan 1
Adliswil 1
Ardabil 1
Belize City 1
Bologna 1
Boydton 1
Brno 1
Busto Arsizio 1
Chengdu 1
Costa Mesa 1
Dalmine 1
Garza García 1
Gunzenhausen 1
Indiana 1
Jian 1
Lanzhou 1
Markdorf 1
Perugia 1
Philadelphia 1
Pune 1
Rome 1
Sacramento 1
Saint Louis 1
Serra Pedace 1
Shaoxing 1
Sibiu 1
Taizhou 1
Thornhill 1
Tokyo 1
Vancouver 1
Walnut 1
Zagreb 1
Totale 940
Nome #
Non-alcoholic fatty liver disease is associated with high prevalence of gastro-oesophageal reflux symptoms 158
Prevalence, characteristics and severity of non-alcoholic fatty liver disease in patients with chronic plaque psoriasis 152
Non-alcoholic fatty liver disease is associated with high prevalence of gastro-oesophageal reflux symptoms 141
[Oxidative stress in metabolic syndrome and nonalcoholic steatohepatitis. Is it possible a role for vitamins in clinical practice?] 115
Hepatocellular carcinoma treated by conventional transarterial chemoembolization in field-practice: serum sodium predicts survival 108
[The treatment of hepatocellular carcinoma: an update] 104
gastroesophageal reflux disease: facts and uncertaines 102
-Fatty liver and drugs 98
Cystic lymphangioma of the mesentery and hyposplenism in celiac disease. 96
Prevalence, characteristics and severity of non-alcoholic fatty liver disease in patients with chronic plaque psoriasis 95
-Nonalcoholic fatty liver disease: defining a common problem 81
Braised liver with herbs: the risks of naturopathic hepatoprotection. 78
The EFSA health claims 'learning experience' 76
Severe acute hepatitis after resumption of interferon-Beta therapy for multiple sclerosis: a word of caution. 76
Long-term maintenance of sustained virological response in liver transplant recipients treated for recurrent hepatitis C 68
Nutritional aspects in patients with non-alcoholic steatohepatitis (NASH) 67
-The natural history and risk factors for progression of non-alcoholic fatty liver disease and steatohepatitis. 56
Liver transplantation in alcoholic patients: Impact of an alcohol addiction unit within a liver transplant center 56
Genetic and environmental factors responsible for oxidative stress in now alcoholic fatty liver disease (NAFLD) 25
Intestinal permeability in nonalcoholic fatty liver disease (NAFLD) 25
PREVALENCE OF NONALCOHOLIC FATTY LIVER DISEASE (NAFLD) AND METABOLIC SYNDROME IN PATIENTS WITH PSORIASIS 21
SERUM SODIUM IS A PREDICTOR OF SURVIVAL FOR "INTERMEDIATE HCC" TREATED WITH TRANSARTERIAL CHEMIOEMBOLIZATION (TACE) 19
A PROPOSAL MODEL FOR THE NON-INVASIVE ASSESSMENT OF HISTOLOGICAL INFLAMMATION IN PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD) 19
Body composition and nutrient utilisation in patients with non-alcoholic steato-hepatitis (NASH) 17
Serum levels of hyaluronic acid and tissue metalloproteinase inhibitor-1 combined with age predict the presence of nonalcoholic steatohepatitis in a pilot cohort of subjects with nonalcoholic fatty liver disease. 17
Prevalence, characteristics and severity of non-alcoholic fatty liver disease in patients with chronic plaque psoriasis 17
Colon diverticular disease 3
Totale 1.890
Categoria #
all - tutte 7.108
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 7.108


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020201 0 11 12 15 22 34 29 8 14 16 15 25
2020/2021166 6 19 1 18 30 7 17 1 30 0 27 10
2021/2022179 4 24 1 18 11 4 2 26 5 7 40 37
2022/2023477 44 57 29 60 43 55 29 40 64 31 16 9
2023/2024259 13 69 10 18 26 39 2 21 1 15 28 17
2024/20259 4 5 0 0 0 0 0 0 0 0 0 0
Totale 1.890